In the precise and demanding field of pharmaceutical manufacturing, understanding the technical specifications of every chemical component is crucial. 2-(Trimethylsilyl)Ethoxymethyl Chloride, a vital intermediate, is no exception. Its defined characteristics, from CAS number to purity levels, are critical for its successful application in the synthesis of complex drug molecules like Ruxolitinib Phosphate.

The compound is identified by its unique CAS number: 76513-69-4. This identifier is fundamental in the chemical industry for ensuring accurate tracking and referencing of chemical substances. Furthermore, its physical state is described as liquid, which dictates specific handling and storage requirements within a manufacturing environment. The specified purity of '>98%' is a non-negotiable aspect, guaranteeing its suitability for sensitive chemical reactions where high precision is paramount.

The usage of 2-(Trimethylsilyl)Ethoxymethyl Chloride is primarily in pharmaceutical synthesis and chemical research. Its role as a key intermediate in the production of Ruxolitinib, a significant JAK inhibitor, highlights its importance in the development of treatments for myelofibrosis and potentially other conditions. This application necessitates adherence to strict quality standards throughout the API production process.

Manufacturers and researchers seeking this compound will find that its technical specifications are readily available, enabling informed procurement decisions. The clarity of these details ensures that the intermediate can be integrated effectively into complex chemical synthesis workflows, contributing to the overall efficiency and success of drug development projects. Adherence to these technical parameters is a cornerstone of reliable chemical manufacturing and quality assurance in the pharmaceutical sector.